Issue 44, 2013

Novel pharmaceutical compositions through co-crystallization of racetams and Li+ salts

Abstract

Grinding of solid brivaracetam (BRV) and seletracetam (SEL) with inorganic lithium salts yields original ionic co-crystals (ICCs) characterized by markedly different thermal properties with respect to pure racetams; solid products have been characterized by single crystal crystallography. It is suggested that co-crystallizing lithium with some racetams could lead to a pharmacologically relevant synergetic association and to development of an original drug substance.

Graphical abstract: Novel pharmaceutical compositions through co-crystallization of racetams and Li+ salts

Supplementary files

Article information

Article type
Communication
Submitted
02 Aug 2013
Accepted
28 Aug 2013
First published
02 Sep 2013

CrystEngComm, 2013,15, 8898-8902

Novel pharmaceutical compositions through co-crystallization of racetams and Li+ salts

J. Wouters, F. Grepioni, D. Braga, R. M. Kaminski, S. Rome, L. Aerts and L. Quéré, CrystEngComm, 2013, 15, 8898 DOI: 10.1039/C3CE41539B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements